Short- and Long-Term Risk Stratification in Acute Coronary Syndromes
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
Prediction of Creatinine Clearance from Serum Creatinine
1976 • 15,066 citations
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
2000 • 4,662 citations
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 • 3,097 citations
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
2001 • 2,126 citations
A Validated Prediction Model for All Forms of Acute Coronary Syndrome
2004 • 1,536 citations
The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
2001 • 1,306 citations
Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease
2000 • 1,220 citations
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article
2002 • 1,109 citations
Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation
2000 • 942 citations
ACC/AHA guideline for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction
2002 • 868 citations
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article
2002 • 835 citations
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction
2000 • 754 citations
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
2001 • 704 citations
N -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease
2003 • 597 citations
N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes
2002 • 569 citations
Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes
2005 • 543 citations
Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis
2000 • 414 citations
C-reactive protein and other inflammatory risk markers in acute coronary syndromes
2003 • 366 citations
The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.
1997 • 357 citations
Troponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction
2002 • 345 citations
Acute Coronary Syndromes in the GUSTO-IIb Trial
1998 • 259 citations
Is early invasive treatment of unstable coronary artery disease equally effective for both women and men?
2001 • 256 citations
Renal function: the Cinderella of cardiovascular risk profile
2001 • 203 citations
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
2002 • 158 citations
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb11Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network (PARAGON-A); Global Use of Strategies To Open occluded arteries in acute coronary syndromes (GUSTO-IIb).
2001 • 145 citations
Resampling and cross-validation techniques: a tool to reduce bias caused by model building?
1997 • 141 citations
Troponin t levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the gusto-iv trial
2003 • 141 citations
Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression
1999 • 124 citations
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb
2001 • 120 citations
Very Early Risk Stratification Using Combined ECG and Biochemical Assessment in Patients With Unstable Coronary Artery Disease (A Thrombin Inhibition in Myocardial Ischemia [TRIM] Substudy)
1998 • 89 citations
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina
2003 • 88 citations
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients
2003 • 82 citations
Admission standard electrocardiogram for early risk stratification in patients with unstable coronary artery disease not eligible for acute revascularization therapy: A TRIM substudy
1999 • 78 citations
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA
2003 • 57 citations
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns
2005 • 17 citations